LexDanaLexDanabeta
Inventor

JOHN THOMAS FEUTRILL

Inventor
AU

Overview

4→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes27%
PatentTitleYear
12,583,836Sulphonamide compounds202612,570,614Phenyl amino pyrimidine compounds and uses thereof202612,215,112CD151 inhibitors202511,352,343Urea derivatives and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to KALA PHARMACEUTICALS INC (1)· patent assignee history
2022Based in US· patent location history
2025Patents assigned to Esfam Biotech Pty Ltd (1)· patent assignee history
2025–2026Based in AU· patent location history
2026Patents assigned to Anaxis Pharma Pty Ltd (1)· patent assignee history
2026Patents assigned to GLAXOSMITH KLINE LLC (1)· patent assignee history
2026Patents assigned to GLAXOSMITHKLINE LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
Anaxis Pharma Pty Ltd12026
Esfam Biotech Pty Ltd12025
GLAXOSMITH KLINE LLC12026
GLAXOSMITHKLINE LLC12026
KALA PHARMACEUTICALS INC12022
Locations
LocationPatentsSpan
AU32025–2026
US12022